Subtopic Deep Dive

Chronic Recurrent Multifocal Osteomyelitis
Research Guide

What is Chronic Recurrent Multifocal Osteomyelitis?

Chronic Recurrent Multifocal Osteomyelitis (CRMO) is an autoinflammatory bone disorder primarily affecting children and young adults, characterized by sterile, multifocal bone inflammation with recurrent episodes.

CRMO presents with multifocal bone pain and sterile osteomyelitis on biopsy, distinguishing it from bacterial infection (Khanna et al., 2009, 358 citations). Jansson et al. (2006, 463 citations) classified non-bacterial osteitis into acute, CRMO, and persistent chronic forms in 89 patients, proposing diagnostic criteria. Over 10 papers from 2005-2019 detail clinical, imaging, and treatment aspects, with cohort studies like Wipff et al. (2014, 271 citations) analyzing 107 French pediatric cases.

15
Curated Papers
3
Key Challenges

Why It Matters

CRMO diagnosis prevents unnecessary antibiotics, as delays lead to prolonged courses and complications (Roderick et al., 2016, 310 citations). Hofmann et al. (2017, 278 citations) outline pathogenesis and NSAID/consensus treatments, guiding pediatric rheumatology. Cohort data from Wipff et al. (2014) identify prognostic factors like multifocality, influencing management and reducing bone damage in autoinflammatory guidelines. Girschick et al. (2005, 284 citations) emphasize histopathology for differentiation from infection.

Key Research Challenges

Diagnostic Delay

CRMO mimics bacterial osteomyelitis, causing referral delays and antibiotic overuse (Roderick et al., 2016). Khanna et al. (2009) highlight imaging patterns like periostitis for differentiation, but biopsy confirmation remains needed.

Pathogenesis Uncertainty

Autoinflammatory mechanisms involve IL-1β and epigenetics, but genetic links are unclear (Surace and Hedrich, 2019; Hofmann et al., 2017). Jansson et al. (2006) found immunological and genetic aspects in 89 patients without consistent markers.

Treatment Response Variability

NSAIDs provide partial relief, but persistent cases require biologics; follow-up shows incomplete resolution (Beck et al., 2010, 225 citations). Wipff et al. (2014) report prognostic factors like age at onset affecting outcomes.

Essential Papers

1.

Classification of Non-Bacterial Osteitis: Retrospective study of clinical, immunological and genetic aspects in 89 patients

Annette Jansson, Ellen D. Renner, Juliane Ramser et al. · 2006 · Lara D. Veeken · 463 citations

Clinical analysis of our cohort leads us to define NBO as a distinct disease entity with three clinical presentations: acute NBO, chronic recurrent multifocal osteomyelitis or persistent chronic NB...

2.

Imaging of Chronic Recurrent Multifocal Osteomyelitis

Geetika Khanna, T. Shawn Sato, Polly J. Ferguson · 2009 · Radiographics · 358 citations

Chronic recurrent multifocal osteomyelitis (CRMO) is an autoinflammatory disorder of children and young adults that is characterized by nonbacterial osteomyelitis. Patients typically present with m...

3.

Chronic recurrent multifocal osteomyelitis (CRMO) – advancing the diagnosis

Marion Roderick, Rahul K. Shah, Valerie E. Rogers et al. · 2016 · Pediatric Rheumatology · 310 citations

<b>Background<br/></b>Chronic recurrent multifocal osteomyelitis (CRMO) is a little known inflammatory bone disease occurring primarily in children and adolescents. Delays in referral and diagnosis...

4.

The Role of Epigenetics in Autoimmune/Inflammatory Disease

Anna E. A. Surace, Christian M. Hedrich · 2019 · Frontiers in Immunology · 297 citations

Historically, systemic self-inflammatory conditions were classified as either autoinflammatory and caused by the innate immune system or autoimmune and driven by adaptive immune responses. However,...

5.

Chronic non-bacterial osteomyelitis in children

H. J. Girschick, P Raab, S Surbaum et al. · 2005 · Annals of the Rheumatic Diseases · 284 citations

6.

Chronic Recurrent Multifocal Osteomyelitis (CRMO): Presentation, Pathogenesis, and Treatment

Sigrun R. Hofmann, Franz Kapplusch, Hermann Girschick et al. · 2017 · Current Osteoporosis Reports · 278 citations

7.

A Large National Cohort of French Patients With Chronic Recurrent Multifocal Osteitis

J. Wipff, Félicie Costantino, I. Lemelle et al. · 2014 · Arthritis & Rheumatology · 271 citations

Objective To document more fully the characteristics of chronic recurrent multifocal osteomyelitis (CRMO) in pediatric patients, to collect data on the outcomes and management of the disease, and t...

Reading Guide

Foundational Papers

Start with Jansson et al. (2006, 463 citations) for classification and criteria in 89 patients; Khanna et al. (2009, 358 citations) for imaging features; Girschick et al. (2005, 284 citations) for histopathology.

Recent Advances

Study Hofmann et al. (2017, 278 citations) for pathogenesis/treatment; Roderick et al. (2016, 310 citations) for diagnostic advances; Surace and Hedrich (2019) for epigenetics.

Core Methods

MRI for multifocal lesions (Khanna et al., 2009); biopsy for sterility; NSAIDs first-line with biologics for refractory cases (Hofmann et al., 2017); cohort analysis for prognosis (Wipff et al., 2014).

How PapersFlow Helps You Research Chronic Recurrent Multifocal Osteomyelitis

Discover & Search

PapersFlow's Research Agent uses searchPapers and citationGraph to map CRMO literature from Jansson et al. (2006, 463 citations), revealing clusters around non-bacterial osteitis classification. exaSearch uncovers cohort studies like Wipff et al. (2014); findSimilarPapers extends to imaging diagnostics from Khanna et al. (2009).

Analyze & Verify

Analysis Agent employs readPaperContent on Hofmann et al. (2017) to extract pathogenesis details, then verifyResponse with CoVe checks claims against Girschick et al. (2005). runPythonAnalysis processes cohort data from Wipff et al. (2014) for survival curves via pandas; GRADE grading scores evidence strength for treatment efficacy.

Synthesize & Write

Synthesis Agent detects gaps in genetic markers post-Jansson et al. (2006), flags contradictions in epigenetic roles (Surace and Hedrich, 2019). Writing Agent uses latexEditText for review drafting, latexSyncCitations for 10+ papers, latexCompile for figures; exportMermaid visualizes diagnostic workflows.

Use Cases

"Extract survival data from CRMO cohorts and plot remission rates."

Research Agent → searchPapers('CRMO cohort') → Analysis Agent → readPaperContent(Wipff 2014) → runPythonAnalysis(pandas plot remission curves) → matplotlib graph of prognostic factors.

"Draft LaTeX review on CRMO imaging diagnostics."

Research Agent → citationGraph(Khanna 2009) → Synthesis Agent → gap detection → Writing Agent → latexEditText('imaging section') → latexSyncCitations(5 papers) → latexCompile → PDF with synced refs.

"Find code for CRMO bone lesion segmentation from papers."

Research Agent → searchPapers('CRMO imaging analysis code') → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → Python scripts for MRI lesion analysis.

Automated Workflows

Deep Research workflow conducts systematic review of 50+ CRMO papers: searchPapers → citationGraph → DeepScan (7-step analysis with GRADE checkpoints) → structured report on diagnostics. Theorizer generates hypotheses on IL-1β role (Ruscitti et al., 2015) via literature synthesis → exportMermaid pathways. DeepScan verifies treatment outcomes from Beck et al. (2010) with CoVe chain.

Frequently Asked Questions

What defines CRMO?

CRMO is sterile multifocal bone inflammation recurring over months, classified under non-bacterial osteitis with three forms by Jansson et al. (2006). It affects children with bone pain, confirmed by biopsy excluding infection.

What are key diagnostic methods?

Whole-body MRI detects multifocal lesions with periostitis (Khanna et al., 2009). Biopsy shows sterile inflammation; criteria from Jansson et al. (2006) aid differentiation.

What are seminal papers?

Jansson et al. (2006, 463 citations) proposes classification; Khanna et al. (2009, 358 citations) details imaging; Roderick et al. (2016, 310 citations) advances diagnosis.

What open problems exist?

Genetic markers remain elusive (Jansson et al., 2006); treatment standardization for refractory cases lacks consensus (Hofmann et al., 2017); long-term outcomes need prospective data.

Research Osteomyelitis and Bone Disorders Research with AI

PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:

See how researchers in Health & Medicine use PapersFlow

Field-specific workflows, example queries, and use cases.

Health & Medicine Guide

Start Researching Chronic Recurrent Multifocal Osteomyelitis with AI

Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.

See how PapersFlow works for Medicine researchers